|Articles|May 1, 2005
- Pharmaceutical Executive-05-01-2005
- Volume 0
- Issue 0
TOC
TOC
Advertisement
Articles in this issue
almost 21 years ago
Pharm Exec Ad Starsalmost 21 years ago
Elephant or Specialist?almost 21 years ago
Global Report: Iron Fistalmost 21 years ago
Washington Report: The Pendulum Swingsalmost 21 years ago
What Does It Take to be a Global Leader in Trainingalmost 21 years ago
Unleash the Tabletsalmost 21 years ago
Eisai's New Leadershipalmost 21 years ago
Superstar Selectionalmost 21 years ago
TOCalmost 21 years ago
Professional Persuasion:101Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
3
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
4
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
5